Given the immunomodulatory role of IBT in a murine model and the fact that microglia, astrocytes, and neurons are the primary source of TNF-α in the CNS (69, 72), it is possible that low TNF-α secretion cannot be compensated in the brain, enabling fungal organisms to establish an infection in patients receiving BTK inhibition. The gene discussed is BTK; the disease is infection.